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SUMMARY
Objective: We present a single-center prospective study, validating the use of 3D
multimodality imaging (3DMMI) in patients undergoing intracranial electroencepha-
lography (IC-EEG).
Methods: IC-EEG implantation preparation entails first designing of the overall strat-
egy of implantation (strategy) and second the precise details of implantation (plan-
ning). For each case, the multidisciplinary team made decisions on strategy and
planning before the disclosure of multimodal brain imaging models. Any changes to
decisions, following disclosure of themultimodalmodels, were recorded.
Results: Disclosure of 3DMMI led to a change in strategy in 15 (34%) of 44 individuals.
The changes included addition and subtraction of electrodes, addition of grids, and
going directly to resection. For the detailed surgical planning, 3DMMI led to a change
in 35 (81%) of 43 individuals. Twenty-five (100%) of 25 patients undergoing stereo-EEG
(SEEG) underwent a change in electrode placement, with 158 (75%) of 212 electrode
trajectories being altered.
Significance: The use of 3DMMImakes substantial changes in clinical decisionmaking.
KEYWORDS: Epilepsy surgery, Image integration, Presurgical evaluation.
Twenty percent to 40% of patients with focal epilepsy are
refractory to medical management, and are candidates for
epilepsy surgery.1 The minimum presurgical evaluation of
these patients includes detailed history and examination,
advanced epilepsy protocol magnetic resonance imaging
(MRI) studies, video electroencephalography (EEG) telem-
etry, and neuropsychological and psychiatric assessment.
Further neuroimaging studies such as fluorodeoxyglucose
positron emission tomography (FDG-PET), ictal single
photon emission computed tomography (SPECT), func-
tional MRI, diffusion tensor imaging (DTI) tractography,
and magnetoencephalography (MEG) may provide further
information to approximate the suspected epileptogenic
zone, and relationship to eloquent cortical areas and white
matter tracts.2
Intracranial EEG (IC-EEG) is indicated in patients with
medically intractable focal epilepsy when noninvasive
investigations have failed to adequately define the epilepto-
genic zone.3 The decision to proceed to IC-EEG, and the
precise location and configuration of the implantation,
arises from a multidisciplinary case review with all the non-
invasive investigations. IC-EEG may take the form of sub-
dural grid electrodes, a combination of grid and depth
electrodes, and by stereotactically placed depth electrodes
(SEEG).
The use of integrated multimodality imaging in epilepsy
surgery is well established.4–6 PET, fluid-attenuated inver-
sion recovery (FLAIR) MRI and SPECT can be coregis-
tered and displayed on neuronavigation systems to unmask
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previously cryptogenic areas of interest to the operating
surgeon and place them in an anatomic framework.6 Corti-
cal motor, sensory, and speech representation mapped by
functional MRI (fMRI), and corticospinal tracts derived
from tractography, can also be displayed to enable resec-
tions of posterior temporal and extratemporal epilepto-
genic lesions in areas close to eloquent brain.7 Finally,
electrode implantations can be visualized in the context of
presurgical investigations by integration of postoperative
CT reconstructions,8 and this is useful in the subsequent
interpretation of IC-EEG recordings.
There are no published data on the use of these tools in
clinical practice. An online questionnaire distributed by our
group (unpublished) indicated that three-dimensional mul-
timodality imaging (3DMMI) was felt to be useful in epi-
lepsy surgery, and that it is underutilized in clinical practice.
Eight of 40 respondents used 3DMMI in clinical practice.
Twenty-eight of 40 deemed 3DMMI as very useful and 7 of
40 deemed 3DMMI as slightly useful in the presurgical
evaluation of epilepsy. The main barriers to implementation
appeared to be cost (21/32) and the complexities of the pro-
cess with a lack of local expertise (12/32).
We have previously reported on the feasibility of using
3DMMI to assist in the presurgical evaluation and surgical
planning of epilepsy surgery in a busy tertiary center.9 The
aim of this study is to validate the use of 3DMMI in clinical
practice with a larger cohort, and demonstrate how it can be
used throughout presurgical evaluation.
Methods
Ethics and recruitment
This project was approved by the joint research ethics
committee of the National Hospital for Neurology and Neu-
rosurgery (NHNN), and University College London (UCL)
Institute of Neurology (ION). All participants were pro-
vided with patient information sheets and gave written,
informed consent.
All individuals with medically refractory focal epilepsy,
undergoing presurgical evaluation for placement of IC-EEG
and possible subsequent neocortical resection between
August 2012 and August 2014, were invited to participate in
the study.
Image integration
Relevant structural and functional image acquisition was
based entirely on clinical need, as determined by the
patient’s consultant neurologist, following discussion and
consensus at the weekly multidisciplinary teammeeting.
Patients undergoing IC-EEG underwent a T1-weighted
Stealth MRI scan with gadolinium for the purposes of
neuronavigation, and a 3D phase-contrast MRI scan for the
purposes of visualizing cortical surface vein anatomy.
Individuals having SEEG also had a CT angiogram (CTA)
to visualize intracerebral arteries.
All available structural and functional imaging modalities
performed in the patient’s presurgical evaluation were
stored on a single workstation. See Tables S1–S3. Data pre-
processing was performed locally when required, prior to
transfer to the workstation for the purpose of image integra-
tion.
Image integration was performed using the AMIRA
(Version 5.4.0; Visualization Sciences Group, Boston, MA,
US) software package, and more recently the EpiNav
(CMIC, UCL, London, United Kingdom) software package.
Image integration is a stepwise process by which each new
modality is coregistered with the base anatomic image
(Stealth T1-weighted MRI with gadolinium injection), and
display settings are adjusted using a range of tools to offer
optimal data presentation and visualization.
The final multimodal image is a 3D-volume-rendered
representation of the brain, with volume- or surface-ren-
dered clusters representing different modalities. The user
can manipulate the final multimodal image in a number of
ways, including alteration of the transparency of the brain
and different modalities, rotation of the image in any plane,
and changing the scaling of the image (Fig. S1). Modalities
are color coded according to a fixed palette devised by our
group (Table S2).
The data are presented at multidisciplinary team meet-
ings, where the overall strategy of implantation (strategy)
are decided, and at surgical meetings, where precise implan-
tation details (planning) are decided. Once both the strategy
and detailed planning are completed and approved by both
neurophysiologist and operating neurosurgeon, the 3D
models generated on AMIRA/EpiNav are exported onto the
S7 StealthStation for intraoperative use during the implanta-
tion of IC-EEG electrodes. The feasibility of this approach
with AMIRA in routine clinical practice was demonstrated
in a pilot study.9 Increasingly image integration and surgical
planning has been performed on the EpiNav software in our
center. EpiNav is an easy to use custom-built software pack-
age dedicated to strategy and planning in epilepsy surgery.
Like AMIRA, EpiNav can be used for rapid image integra-
tion and 3D visualization, In addition to this, EpiNav has
added functionality, including a trajectory planner module
for the placement of depth electrodes and a dedicated export
module for archiving models and plans directly onto the S7
StealthStation (Table S3).
Following implantation of electrodes, the localization of
electrode contacts relative to structural and functional data
can be examined by reconstructing the electrodes on the
3DMMI using AMIRA/EpiNav. Postimplantation CT imag-
ing is coregistered to the T1 image (Fig. 1).
Planning process
Two “milestone” discussions were identified in all
patients undergoing consideration of IC-EEG. The first is
the implantation strategy and the second is the precise surgi-
cal planning (Fig. 2).
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Implantation strategy
The implantation strategy is the definitive decision on
whether to proceed to IC-EEG, directly proceed to resec-
tive surgery, or abandon the possibility of surgical treat-
ment. In the cases of IC-EEG, a further decision is made
on the favored strategy of using subdural grid electrodes,
depth electrodes, or a combination of both, and how the
desired coverage could be achieved. This meeting typi-
cally takes place a number of months prior to implanta-
tion. The implantation strategy is determined primarily
by clinical neurophysiologists and neurologists in a case-
centered meeting. The presurgical evaluation, video
telemetry, and neuroimaging are reviewed, followed by
discussion led by the neurophysiologists on how best to
proceed. Following consensus on the implantation strat-
egy, the 3DMMI is disclosed to the group using the
AMIRA workstation/Epinav workstation, and/or the S7
StealthStation. Any additional insights are recorded, as
are any changes to the agreed strategy. The primary end
point is whether disclosure of 3DMMI changes implanta-
tion strategy.
Precise surgical planning
The precise surgical planning specifies the implementa-
tion of the IC-EEG. It is carried out by the consultant neuro-
surgeon and a neurosurgical trainee, and is performed on the
EpiNav workstation and/or S7 StealthStation (AMIRA has
no surgical planning functionality). This typically takes
place one week before the implantation. The precise surgi-
cal planning consists of planning trajectories for the inser-
tion of depth electrodes, the identification of cortical
anatomy, and the planning of subdural grid placement. Fol-
lowing completion and documentation of the provisional
plan, 3DMMI is disclosed on the EpiNav workstation/neu-
ronavigation system, with the models displayed in 3D and
also as contours on the orthogonal plane viewfinder. Any
A
B
Figure 1.
(A) Left: Volume rendering of cortex (gray) with addition of motor fMRI activation (green) and vein segmentation (cyan) in the context of
the craniotomy bone flap, visualized by CT reconstruction. Right: Intraoperative photograph to show cortical surface and overlying vascu-
lar structures. (B) Left: Addition of subdural grids, with reconstruction on AMIRA. Right: Intraoperative photograph to show positioning
of subdural grids on cortical surface.
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changes to the provisional plan are recorded. These may
include changes in electrode arrangement, changes in elec-
trode entry and target points, and changes to grid position-
ing. The primary end point is whether disclosure of 3DMMI
changes the precise surgical planning.
Results
Demographics
Table 1 demonstrates the demographics and overall
results of the 54 patients in the study.
The median age of the group was 32.5 years (range 19–
60), and the median duration of epilepsy was 20.5 years
(range 4–46). Thirty-seven (69%) of 54 patients were con-
sidered to have epilepsy that originated outside the temporal
lobe, and 21 (39%) of 54 patients had no clear structural
lesion.
All patients had a model of their cortex built, derived
from cortical segmentations of a T1-weighted MRI gener-
ated by Freesurfer (Version 5.0.0; Martinos Center for
Biomedical Imaging, Charlestown, MA, U.S.A.). These
cortical models provided the anatomic framework on
which to add other modalities.
A further 253 imaging models were created and added
onto these cortex models, resulting in a mean 5.7 models per
patient (Fig. S2). There were 82 models that helped to infer
the epileptogenic zone, 52 models of tractography, and 69
models of venous/arterial vasculature. Four patients under-
going grid implantations had preoperative grid electrode
models built. All 25 patients undergoing SEEG had models
of individual electrode trajectories.
Disclosure of 3DMMI
Fifty-four patients were studied in this series, and the
disclosure of 3DMMI changed some aspect of management
in 43 (80%) of 54 cases. For each case, the change was in
implantation strategy, precise surgical planning, or both.
Implantation strategy
Forty-four patients entered the implantation strategy arm.
See Figure 3A for an overview of the effect of 3DMMI on
implantation strategy. The remaining 10 patients in the
study were not included in this arm of evaluating the impact
of 3DMMI on implantation strategy.
In two patients there was clinical equipoise as to whether
an implantation was necessary or resection could be rec-
ommended without IC-EEG. With patient 21, this was due
to the proximity of the presumed epileptogenic zone (EZ)
to the motor cortex and corticospinal tract. Following dis-
closure of 3DMMI, the team felt it was safe to proceed
with resection. With patient 52, it was thought not possible
to completely resect an extensive structural lesion. Disclo-
sure of the models led the team to consider that an implan-
tation was necessary to precisely localize the EZ and offer
safe resective surgery.
Forty-two patients were initially put forward for an intra-
cranial implantation: 18 for grid implantations and 24 for
stereo-EEG (SEEG) implantations. Disclosure of the mod-
els led to a change in the implantation strategy in 13 (31%)
of 42 cases. There were 5 (28%) of 18 changes in grid strat-
egy and 8 (33%) of 24 changes in SEEG strategy.
The details of the 15 changes in implantation strategy are
listed in the Table 2.
Precise surgical planning
Forty-three patients entered the precise surgical planning
arm. Of the 11 patients not included in this arm, one patient
declined to proceed with an implantation, one patient
proceeded direct to a resection, four patients have not had
precise surgical planning done and five patients did not have
their planning recorded. See Figure 3B for an overview of
the effect of 3DMMI on surgical planning.
Five patients were planned for grid implantations only,
13 patients were planned for a combination of grid and
depth electrode implantations, and 25 patients were planned
for SEEG implantations.
Disclosure of the models did not change the planning in
the five cases using a strategy of subdural grids without
depth electrodes. Disclosure of the models changed 10
(77%) of 13 cases using a combination of grids and depth
electrodes. Disclosure of the models changed 25 (100%) of
25 cases using a strategy of SEEG. One hundred fifty-eight
(75%) of 212 electrodes were changed, with 124 changes to
entry points, 28 changes to target points, and the addition of
6 further electrodes by the surgeons to optimize coverage.
The most common reasons for changes to entry points were
to minimize the risk of a vascular injury, by increasing the
Figure 2.
The workflow in this case series.
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distance from a cortical surface vein (51) or by centering on
the crown of the gyrus (44).
The details for the changes in SEEG implantation plan-
ning are listed in Table 3.
Outcomes
In total 46 patients in this series underwent an IC-EEG
(Table 1). Thirty-five (76%) of 46 patients were put for-
ward for a definitive cortical resection following identifica-
tion of the presumed epileptogenic zone. Twenty-one
patients have had definitive cortical resections completed,
and there is 1-year follow-up on 17 of these. Ten (59%) of
17 patients have International League Against Epilepsy
(ILAE) Class I outcomes. Of the 11 patients excluded from
surgery, the presumed epileptogenic zone was found at
multiple sites in four cases, diffuse in three cases, over-
lapped with eloquent cortex in one case, and was not
clearly identified in one case. In the remaining two cases,
the patients did not have seizures and the implantations
were abandoned after a given period of time.
Discussion
Summary
3DMMI was employed in the presurgical evaluation and
surgical management of a consecutive series of patients
with medically refractory epilepsy undergoing IC-EEG
implantation. Of the 54 patients studied, the disclosure of
3DMMI changed some aspect of management in 43 (80%)
of 54 cases, with a 34% rate of change in strategy, and 81%
rate of change in planning. The total added value of 3DMMI
can be expressed in our series as follows: three patients
moved out of clinical equipoise into resective surgery, IC-
EEG, and rediscussion at MDT, respectively; one patient
A
B
Figure 3.
(A) An overview of the effect of 3DMMI on implantation strategy in this case series. (B) An overview of the effect of 3DMMI on precise
surgical planning in this case series.
Epilepsia ILAE
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underwent a change in IC-EEG method, 11 patients under-
went a fine-tuning of implantation strategy; and 35 patients
underwent a change in precise surgical planning, compris-
ing of changes to three grids and 173 depth electrodes in
total. This suggests that 3DMMI has a role to play in evalua-
tion and management.
The implantation strategy, that is the design of the gen-
eral method for implantation, changed in 15 of 44 individu-
als. These changes were not generally from one technique
to another, rather a fine tuning of implantation design. This
includes the addition of electrodes to improve coverage of
structural, functional, and neurophysiologic data, and the
reduction of electrodes to minimize surgical risk and
increase efficiency.
The choice of technique for implantation is dependent on
a number of factors, including hypothesis for EZ, need for
functional mapping, surgical risk, and expertise of the treat-
ing team. In summary, it is our current view that, in general,
patients with suspected seizure onset at the cortical surface,
close to eloquent areas, will be more suited to subdural grid
electrode implantation to facilitate extensive cortical map-
ping, whereas patients with suspected seizure onset at the
depths of a sulcus, or areas of cortex not accessible by grids,
are more likely to benefit from SEEG. The strategy for
implantation was therefore based largely on the neurophysi-
ologic hypothesis, which was arrived at prior to and inde-
pendently of disclosure of 3DMMI. We would therefore not
anticipate any substantial change in the chosen implantation
technique with 3DMMI disclosure.
The results do, however, indicate how strategies can be
improved when seen in the context of 3DMMI. This is in
comparison to the previous convention in which some
imaging is presented in 2D (i.e., structural MRI and FDG-
PET), and some imaging is not presented at all (fMRI, DTI
tractography). With implantation of subdural electrodes it
is possible to accurately gauge sizing of the grids and strips
to ensure spatial coverage of underlying structural and
functional areas of interest. We found this particularly use-
ful in ensuring adequate cortical coverage for the purposes
of functional mapping of the motor cortex and language
areas, and in covering areas of interest such as FDG-PET
hypometabolism. With SEEG, the 3D spatial arrangement
of depth electrodes is difficult to appreciate and communi-
cate in 2D form. Adjustments can be made to “fill” any
obvious gaps in spatial coverage, and to remove electrodes
that duplicate coverage and cause congestion. Furthermore,
deep targeting of functional areas of interest is only possi-
ble with 3DMMI. We conclude that designing implanta-
tions is suboptimal without the ability to visualize the 3D
Table 2. The changes in strategy following disclosure of 3DMMI in this case series
Patient Initial strategy Change in strategy Reason
18 Grids Addition of depth electrodes Improve coverage around lesion
20 Grids Addition of depth electrodes Improve coverage around lesion
21 Equipoise Proceed to resection Good spatial corroboration between lesion and SPECT, anterior to motor areas
22 SEEG Addition of depth electrodes Target MEG dipole in insula
24 SEEG Removal of depth electrodes Difficult implementation of SEEG
25 SEEG Re-discussion in MDT No initial consensus on agreed strategy
27 SEEG Addition of depth electrodes Improve coverage around lesion
29 Grids Displacement of grid Include coverage of PET hypometabolism
31 SEEG Grids Anterior frontal MEG dipole, more amenable to grid coverage
32 Grids Addition of depth electrodes Improve coverage of tubers
34 SEEG Removal of depth electrodes Improve efficiency of implantation
36 Grids Displacement of grid Include coverage of PET hypometabolism
42 SEEG Removal of depth electrode Improve efficiency of implantation
47 SEEG Addition of depth electrode Improve coverage to map optic radiation
52 Equipoise Proceed to SEEG Further localize EZ in large low-grade glioma
MDT, multidisciplinary team meeting; SEEG, stereoelectroencephalography; SPECT, single photon emission computed tomography; MEG, magnetoencephalog-
raphy; PET, positron emission tomography; EZ, epileptogenic zone.
Table 3. The causes of change in precise planning of
SEEG following disclosure ofmodels
Changes in electrode Number
Changes in entry point 124
Increase distance from vein 51
Center on gyral crown 44
Improve feasibility of trajectory 14
Use of gyral anatomy 8
Center on motor area (fMRI) 6
Avoid superficial temporal artery 1
Changes in target point 28
Target structural lesion 10
Increase distance from artery 8
Avoid electrode congestion 3
Improve feasibility of trajectory 3
Target PET/MEG 2
Target language areas (fMRI) 1
Target motor areas (fMRI) 1
Added electrodes 6
Total 158
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spatial relationships between regions of interest and
implanted contacts.
Precise surgical planning, that is, the planning of the
details of the implantation, changed in 35 of 43 cases.
Disclosure of 3DMMI did not change surgical planning
in cases of grid implantation. Grid planning is essentially
the determination of the sizing and positioning, which is
completed in the strategy phase. Neurosurgeons use
3DMMI to inform the correct placement of the grids, and
the optimal placement of the overlying craniotomy, but
there is little discrete planning to record.
Disclosure of 3DMMI changed surgical planning in all
25 cases of SEEG. In total, the majority of electrodes (158/
212, 75%) were altered following disclosure of 3DMMI.
This supports the notion that 3DMMI is helpful for the
design and planning of SEEG. Entry points were changed
primarily to reduce the risk of hemorrhagic complications
associated with cortical vein injury, and to center on the
gyral crown to avoid encroaching pial boundaries (see
Fig. S3). Other reasons for change included accurate target-
ing of superficial cortical structures such as motor cortex,
and the facilitation of improved trajectory angles through
the skull that were easier to implement. Target points were
changed primarily to locate important structural and func-
tional areas of interest, such as deep areas of focal cortical
dysplasia or FDG-PET hypometabolism.
After planning all of the individual electrodes, 3DMMI
allowed the clinical team to review the assembled implanta-
tion, and identify defects in spatial coverage and areas of
electrode congestion. In some cases this led to the addition
of depth electrodes, or the further alteration in individual
depth electrode trajectory.
In practice, surgical planning of SEEG is a complex pro-
cess; in any electrode arrangement, the entry and target
point of a solitary electrode can affect the entire arrange-
ment, and it is not uncommon to make several changes fol-
lowing disclosure of 3DMMI. We concede that it is possible
to plan in 2D and arrive at reasonable electrode configura-
tions with safe trajectories. However, 3D representations of
gyral anatomy and vasculature, in particular, allow the sur-
geon to make small changes to electrode positioning with a
clear understanding of how this affects proximity to other
structures. We believe this is the crucial difference to plan-
ning in 2D, and makes for a more informed method that
optimizes safety considerations.
General
Throughout this study, there has been a development in
understanding how 3DMMI can be used to improve clinical
care. In terms of modalities, structural and functional data
appear most relevant in determination of strategy, whereas
vascular and gyral anatomy appear most relevant in precise
planning. However, disclosure of 3DMMI does not always
represent a change in decision making, but rather an added
tool to support and inform decision making. Feedback from
the neurophysiology and neurosurgery teams suggests the
following benefits of 3DMMI in clinical practice.
1 3D spatial concordance between structural and functional
localizing investigations for epileptogenic zone.
2 3D spatial relationship of presumed epileptogenic zone to
surrounding critical structures.
3 Avoidance of hemorrhagic complications in the planning
and implementation of SEEG.
4 Planning of grid placement for purposes of functional cor-
tical mapping.
5 Use of vessel segmentation and models of segmented
gyral anatomy to provide navigational tool in craniotomy.
With subdural grid implantations and subsequent cortical
resections, 3DMMI can be used by the surgeon as an addi-
tional navigation tool. For example, models of cortical
veins, allied with segmentations of complex gyral anatomy
such as the central sulcus and pre- and postcentral gyrus,
can provide valuable corroboration tools to orientate the
surgeon10 and to check neuronavigation registration accu-
racy. This becomes particularly powerful when the models
are propagated as 2D models through the operating micro-
scope.
In addition to using 3DMMI in presurgical evaluation, we
also used 3DMMI postoperatively to demonstrate the spatial
positioning of electrode contacts using the methodology
outlined by Chamoun et al.8 (see Fig. 1B). This involves
the coregistration of postoperative CT to the preoperative
imaging, followed by surface extraction and thresholding to
build 3D models of implanted electrodes (Fig. 1). This pro-
vided a crucial tool in the understanding of implantation
accuracy and outcome, and interpreting the generated neu-
rophysiologic data. This is especially the case in those grid
electrode implantations where it is not possible to directly
visualize and photograph the cortical surface, for example,
orbitofrontal cortex, and in depth electrodes targeting deep
structures, for example, anterior hippocampus. There is the
obvious limitation of brain shift, which is more pertinent to
grid electrode implantations with associated large cranioto-
mies, but can also occur in SEEG with the escape of cere-
brospinal fluid and effect of gravity on head position. This
can be overcome by acquiring postoperative MRI, which
directly shows electrode positioning in an anatomic context.
However, individual centers have to pass their own safety
testing prior to acquisition of MRI with implantations in
situ. In addition, there is the possibility of electrode contact
shift during the recording period and after postoperative
imaging, which may falsely localize the epileptogenic zone
on the cortical surface.
Implications
This study demonstrates the potential role of 3DMMI
in clinical practice. We anticipate that 3DMMI will
become increasingly important in the future, for several
reasons. Ongoing research in advanced imaging tech-
niques, such as voxel-based analysis, EEG-fMRI, and
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magnetoencephalography,2 will add further modalities to
be considered in 3D anatomic space and presented to the
clinical team. At the same time, there is a trend toward
less-invasive and better-tolerated investigations and treat-
ments in neurosurgery, with much hope for neuroablative
techniques such as SEEG-guided radiofrequency thermo-
coagulation, MR-guided laser therapy, and ultrasound
therapy.11 A planning system that presents 3DMMI multi-
modal data and communicates with existing neuronaviga-
tion software will be essential in the delivery of future
implantations and treatments.
Limitations
The aim of the current study was to describe how the use
of 3DMMI can change clinical management. The study does
not specifically address whether the changes in practice, as
a direct result of disclosure of the 3DMMI, make any sub-
stantial difference to the outcomes in these patients.
Although it is intuitive to think that more data will lead to
better decision making and therefore better outcomes, we
do not have evidence for this.
Class I evidence for the use of 3DMMI in epilepsy sur-
gery would require the design of a randomized controlled
trial. This is problematic in clinical practice for the follow-
ing reasons.
1 Epilepsy, even if restricted to refractory focal epilepsy, is
an extremely heterogeneous condition with a heteroge-
neous population group.
2 Epilepsy surgery is relatively uncommon, with low num-
bers.
3 Assessing outcome after epilepsy surgery is complex.
4 Use of models already partially integrated into the clinical
pathway.
An alternative approach is to examine secondary end
points that are surrogate markers for outcome. First, did the
patients undergoing IC-EEG achieve a satisfactory conclu-
sion to their implantation with regard to seizure localiza-
tion? Thirty-five of 46 patients have been put forward for
cortical resection and 11 of 46 patients have been excluded
from resective surgery in this series. The epileptogenic zone
was satisfactorily identified in up to 43 of the 46 cases stud-
ied. This indicates that the final implantations were well
designed. It will be some time before robust seizure out-
come data are available in this patient group. At the present
time 10 (59%) of 17 patients have ILAE Class I outcomes at
1 year of follow-up. These results are consistent with the lit-
erature when one considers the difficult patient group, with
high rates of nonlesional and extratemporal epilepsy.
Second, did the patients undergoing IC-EEG have any
complications as a result of IC-EEG implementation?
There was one case of a hemorrhagic complication using a
frameless stereotactic method for SEEG implantation of a
total of 212 electrodes implanted (0.5%). This patient was
asymptomatic and did not require any further treatment.
With the grid cases, there were two cases of subdural
hematomas that required evacuation and precluded contin-
ued IC-EEG recording, and two cases of infection. This
complication rate is comparable with that in the litera-
ture.12 Overall these events were not thought to be a result
of the use of 3DMMI, and these surrogate markers are
suggestive of good clinical practice.
A further caution is that the use of 3DMMI is dependent
on the generation of high-quality input data, which is well
understood by the end user. We know that some data sets
will be reliable and reproducible such as structural MRI,
and other sets will have considerable interuser variability
such as tractography.13 Interpretation of these within an
integrated data set requires differential levels of caution
and confidence by the neurophysiologist and neurosurgeon.
Taking the example of tractography, we recommend using
this as a guide to the orientation of large white matter
tracts, and intraoperative mapping is required for definitive
identification. Similarly, the sensitivity of 3D phase con-
trast MRI is limited, and in our experience the segmenta-
tion of cortical veins derived from this modality is
incomplete at the convexity of the hemispheres. It is there-
fore crucial for the surgeon to check the “probes eye view”
planes on the MRI with gadolinium, prior to implementing
a trajectory planned with the vascular models.
The complexity of presurgical evaluation gives rise to
two further limitations with this study. First, there is the dif-
ficulty associated with capturing benefits. The terms “strat-
egy” and “planning” are divisions made in a stepwise
process. Presurgical evaluation extends over many months
and often involves the exchange of ideas between the treat-
ing neurology and surgical team at multiple points along the
course. To capture the impact of 3DMMI, a degree of rigid-
ity was applied to this process, with the distinction of
implantation strategy from precise surgical planning.
Second, there is difficulty capturing the entire workflow
for a given number of patients. Because this study ran for
2 years, it represents a snapshot of the presurgical evaluation
and surgical management in our unit. Although 54 patients
passed through the study, only 44 were evaluated for strat-
egy, 43 for precise surgical planning and 46 for outcome.
The reasons for this were given earlier and reflected in the
chronologic order of Table 1; any attempt to homogenize the
results to only patients passing through the entire process
with 1-year follow-up would result in much data loss.
Finally, the generalizability of our findings needs to be
confirmed in other centers that do not have the same degree
of interest and expertise in 3DMMI. The EpiNav software is
being made available to other units for this express purpose.
FurtherWork
The next logical step to this work is to examine the utility
of 3DMMI in planning definitive cortical resections. This is
especially pertinent following SEEG implantations, where
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the EZ may be deep, difficult to access, and without clear ana-
tomic borders. In the present study for extratemporal resec-
tions, the surgeon used the spatial positioning of implanted
electrodes implicated in seizure origin, and aimed to remove
the entirety of any segmented structural lesion present. In the
future, we plan to generate resection models to guide surgery
that incorporate advanced imaging techniques and neurophys-
iologic data and that respect anatomic boundaries.
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Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Table S1. The imaging modalities used in this series. ES,
Epilepsy Society; NHNN, National Hospital for Neurology
and Neurosurgery;MEG,magnetoencephalography; SPECT,
single photon emission computed tomography; FDG-PET-
fluorodeoxyglucose positron emission tomography; DTI,
diffusion tensor imaging.
Table S2. The color palette used to display multimodality
in this series.
Table S3.Comparison of AMIRA and EpiNav software.
Figure S1. Volume rendering of cortex (gray) displayed
in AMIRA with the following associated modalities: focal
cortical dysplasia (red), FDG-PET hypometabolism (pur-
ple), hand motor fMRI (green), corticospinal tractography
(blue), veins (cyan).
Figure S2. The imaging modalities used in the case
series.
Figure S3. 3D model of the precise surgical planning of
SEEG on EpiNav. (A) Prior to disclosure of 3DMMI; (B)
following disclosure of 3DMMI.
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